IL-33 signals through its receptor ST2 are key for protective CTL responses to replicating viruses,31 and IL-33 signals critically augment CTL responses to artLCMV-vectored immunization and the resulting tumor control.29 This evidence concerns the gene IL33 and neoplasm.